source
- Novo and Pfizer say MFN pricing agreements remain unchanged despite Democratic gains in CongressOn their third‑quarter earnings calls, the CEOs of Novo Nordisk and Pfizer said the Most Favored Nation drug‑pricing contracts they signed under the previous administration are still in effect and…
- nPhase secures $30M Series D to grow AI-driven clinical data platformCRO nPhase announced it has closed a $30 million Series D financing round. The capital will be directed toward expanding its AI-native clinical data platform that debuted in September, which aims t…